Tenecteplase With or Without Mechanical Thrombectomy in Acute Ischemic Stroke at 4.5 to 24 h: An Updated Meta-Analysis of Randomized Controlled Trials

作者
Beatrice Dell’Acqua,Carmelina Maria Costa,Andrea Cerri,Alessandro Francia,Simone Vidale
出处
期刊:Neurology International [PAGEPress (Italy)]
卷期号:18 (6): 116-116 被引量:1
标识
DOI:10.3390/neurolint18060116
摘要

Background and Purpose: Tenecteplase (TNK) within 4.5 h from symptom onset is not inferior to alteplase in treating ischemic stroke. In recent years, some randomized controlled trials (RCTs) have investigated the efficacy of extending the therapeutic window up to 24 h. This updated meta-analysis aims to synthesize the results of these RCTs comparing TNK to the best medical treatment (BMT) with or without endovascular thrombectomy. Methods: In accordance with PRISMA guidelines, all RCTs comparing TNK with BMT in adult patients between 4.5 and 24 h were systematically searched. The primary endpoint was good functional outcome at 90 days (mRS 0–2). Secondary endpoints included excellent outcome (mRS 0–1), symptomatic intracerebral hemorrhage (sICH), 90-day mortality, complete reperfusion at 24 h. Odd and Hazard ratios (ORs; HRs) were pooled using meta-analytic methods. Results: A total of seven RCTs involving 1754 patients were included. The rates of the primary endpoint were higher in TNK-treated patients (HR: 1.15; 95% CI: 1.03–1.27), as were rates of excellent functional outcome (HR: 1.29; 95% CI: 1.08–1.55). In the subgroup receiving intravenous therapy (IVT) alone, the primary endpoint was significantly more frequent in the TNK group than in the BMT group (OR: 1.47; 95% CI: 1.17–1.84; p for heterogeneity < 0.0001). TNK treatment was also associated with higher reperfusion rates compared with BMT, reflecting a greater proportion of saved ischemic penumbra as assessed via perfusion imaging. Although symptomatic intracranial hemorrhage (sICH) occurred more frequently in TNK-treated patients, the difference did not reach statistical significance, and mortality rates were comparable between treatment groups. Conclusions: Tenecteplase administered between 4.5 and 24 h is associated with improved rates of both good and excellent functional outcomes compared with BMT, especially in patients treated with IVT alone. Additionally, TNK is linked to higher rates of reperfusion.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
树123发布了新的文献求助10
2秒前
会飞的鹦鹉完成签到,获得积分10
3秒前
3秒前
热心的咖啡豆完成签到 ,获得积分10
5秒前
UHPC完成签到,获得积分10
6秒前
十四行诗发布了新的文献求助10
6秒前
科研通AI2S的应助被vividtry采纳,获得10
6秒前
搜集达人的应助被楠小楠采纳,获得10
6秒前
小蘑菇的应助被楠小楠采纳,获得10
6秒前
烟花的应助被楠小楠采纳,获得10
7秒前
香蕉觅云的应助被SHNU_YS采纳,获得10
7秒前
7秒前
李健的小迷弟的应助被楠小楠采纳,获得10
7秒前
7秒前
zs发布了新的文献求助30
7秒前
不放弃完成签到,获得积分10
7秒前
今后的应助被马浩然采纳,获得10
7秒前
HYYY发布了新的文献求助20
8秒前
单薄幻梦发布了新的文献求助10
8秒前
9秒前
sunny完成签到,获得积分10
9秒前
丘比特的应助被September采纳,获得10
10秒前
青枣不甜完成签到,获得积分10
11秒前
cdercder的应助被fsdgsd采纳,获得10
11秒前
所所的应助被学阿斗采纳,获得10
12秒前
YXM发布了新的文献求助10
12秒前
纯真大象发布了新的文献求助10
12秒前
12秒前
maT发布了新的文献求助10
12秒前
szztty发布了新的文献求助10
13秒前
小马甲的应助被kuku采纳,获得10
13秒前
sunny完成签到,获得积分10
14秒前
qin202569发布了新的文献求助10
14秒前
繁荣的瑛的应助被楠小楠采纳,获得10
15秒前
初景的应助被楠小楠采纳,获得20
15秒前
科研通AI2S的应助被楠小楠采纳,获得10
15秒前
科研通AI6.4的应助被楠小楠采纳,获得10
15秒前
余香的应助被楠小楠采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178960
求助须知:如何正确求助?哪些是违规求助? 9569638
关于积分的说明 21805682
捐赠科研通 7774071
什么是DOI,文献DOI怎么找? 3432955
关于科研通互助平台的介绍 2556897
邀请新用户注册赠送积分活动 2478640